Inherited prothrombotic risk factors in children with hereditary angioedema
Inherited prothrombotic risk factors in children with hereditary angioedema
Aim: Hereditary angioedema is characterized with recurrent mucocutaneous angioedema, abdominal pain, edema of larynx andextremities. Dermal vascular thrombosis and systemic coagulation may occur in patients with hereditary angioedema due toinhibition of activated factor XII, thrombin and plasmin. Aim of this study was to screen patients with HAE for prothrombotic geneticrisk factors before treatment.Material and Methods: Ten patients with hereditary angioedema who were followed up at our clinic were included in our study. Thetype and frequency of attack, use of prophylaxis and family history of hereditary angioedema were questioned and prothromboticrisk factors were studied.Results: Among the 10 included patients, five of them were male (50%) and five were female (50%). Four patients had abdominaledema (40%), four patients had edema of hands, feet and face (40%). One patient (10%) had heterozygous factor V G1691A mutation,another one had also heterozygous protrombin G20210A mutation. The heterozygous methylene tetrahydrofolate reductase (MTHFR)mutation were identified in seven patients (70%) and homozygous MTHFR mutation were found two patients (20%).Conclusion: In patients with hereditary angioedema, evaluation of protrombotic risk factors was crucial to estimate attack frequencyseverityand treatment related thrombosis risk.
___
- 1. Bowen T, Cicardi M, Farkas H, et al. Canadian 2003
international consensus algorithm for the diagnosis,
therapy, and management of hereditary angioedema. J
Allergy Clin Immunol 2004;114:629-637.
- 2. Agostoni A, Aygören-Pürsün E, Binkley KE, et al. Hereditary
and acquired angioedema: problems and progress:
proceedings of the third C1 esterase inhibitor deficiency
workshop and beyond. ms and progress: proceedings of the
third C1 esterase inhibitor deficiency workshop and beyond
2004;114:51-131.
- 3. Starr JC, Brasher GW, Rao A, et al. Erythema marginatum
and hereditary angioedema. South Med J 2004;97:948-50.
- 4. Cicardi M, Aberer W, Banerji A, et al; HAWK under the
patronage of EAACI (European Academy of Allergy and
Clinical Immunology). Classification, diagnosis, and
approach to treatment for angioedema: consensus report
from the Hereditary Angioedema International Working
Group. Allergy 2014;69:602-16.
- 5. Maurer M, Magerl M, Ansotegui I, et al. The international
WAO/EAACI guideline for the management of hereditary
angioedema-The 2017 revision and update. Allergy. 2018
Jan 10.
- 6. Crowther M, Bauer KA, Kaplan AP. The thrombogenicity
of C1 esterase inhibitor (human): review of the evidence.
Allergy Asthma Proc 2014;35:444-53.
- 7. Bowen T, Cicardi M, Bork K, et al. Hereditary angioedema:
a current state-of-the-art review, VII: Canadian Hungarian
2007 International Consensus Algorithm for the Diagnosis,
Therapy and Management of Hereditary Angioedema. Ann
Allerg Asthma Immunol 2008;100:30-40.
- 8. Nanda MK, Elenburg S, Bernstein JA, et al. Clinical features
of pediatric hereditary angioedema. J Allergy Clin Immunol
Pract 2015;3:392-5.
- 9. Read N, Lim E, Tarzi MD, et al. Paediatric hereditary
angioedema: a survey of UK service provision and patient
experience. Clin Exp Immunol 2014;178:483-8.
- 10. Bennett G, Craig T. Hereditary angioedema with a focus on
the child. Allerg Asthma Proc 2015;36:70-3.
- 11. Nygren A, Nordenfelt P, Lindfors A, et al. Swedish children
with hereditary angioedema report good overall health and
quality of life despite symptoms. Acta Paediatrica. 2016;
105: 529-34.
- 12. Kesim B, Uyguner ZO, Gelincik A, et al. The Turkish Hereditary
Angioedema Pilot Study (TURHAPS): the first Turkish
series of hereditary angioedema. Int Arch Allergy Immunol
2011;156:443-50.
- 13. Psarros F, Koutsostathis N, Farmaki E, et al. Hereditary
angioedema in Greece: the first results of the Greek
hereditary angioedema registry. International Arch Allergy
Immunol 2014;164:326-32.
- 14. Jose J, Zacharias J, Craig T. Review of select practice
parameters, evidence-based treatment algorithms, and
international guidelines for hereditary angioedema. Clin Rev
Allerg Immunol 2016;51:193-206.
- 15. Farkas H, Kőhalmi KV, Veszeli N, et al. Risk of
thromboembolism in patients with hereditary angioedema
treated with plasma-derived C1-inhibitor. Allerg Asthma
Proc 2016;37:164-70.
- 16. Tunçay A, Şener EF, Emiroğulları ÖN. Investigation of genetic
polymorphisms in infective endocarditis and artificial valve
thrombosis. Erciyes Med J 2017;39:63-6.
- 17. Ozcan A, Canpolat M, Doganay S, et al. Cerebral sinus venous
thrombosis and prothrombotic risk factors in children: A
single-center experience from Turkey. J Pediatr Hematol
Oncol 2018;40:369-72.
- 18. Per H, Unal E, Poyrazoglu HG, et al. Childhood stroke: results
of 130 children from a reference center in central anatolia,
Turkey. Pediatr Neurol 2014;50:595-600.
- 19. Yilmaz E, Bayram Kacar A, Bozpolat A, et al. The relationship
between hematological parameters and prognosis of
children with acute ischemic stroke. Child Nervous Syst
2018;34:655-61.
- 20. Van Geffen M, Cugno M, Lap P, et al. Alterations of coagulation
and fibrinolysis in patients with angioedema due to C1-
inhibitor deficiency. Clin Exp Immunol 2012;167:472–8.
- 21. Celikel S, Buyukasik Y, Karakaya G, et al. Hereditary
angioedema associated with heterozygous factor V Leiden
mutation in a patient with Purpura fulminans. Int Arch Allerg
Immunol 2007;142:175-8.
- 22. De Maat S, Hofman ZLM, Maas C. Hereditary angioedema:
the plasma contact system out of control. J Thromb
Haemost. 2018;16:1674-85.
- 23. Maas C, Renne T. Coagulation factor XII in thrombosis and
inflammation. Blood 2018;131:1903-9.
- 24. Moreno AS, Valle SO, Levy S, et al. Coagulation Factor
XII Gene Mutation in Brazilian Families with Hereditary
Angioedema with Normal C1 Inhibitor. Int Arch Allerg
Immunol 2015;166:114-20.
- 25. Unal E, Mutlu FT, Karakukcu M. The importance of MTHFR
polymorphisms in pediatric cerebral stroke. Childs Nerv
Syst 2012;28:13.